Connect Sign In
LabMind podcasts
Paul, recovered and thriving, looks out over Sacred Rim, Wyoming, celebrating life after a near-fatal accident. |
November 25, 2025 |
12 Strangers Saved His Life, Now He Hopes His Story Inspires You To Donate Blood Paul’s life was saved thanks to 12 generous blood donors, demonstrating the power of community and compassion. |
The RESULTS Act would block looming cuts in payments for lab testing services and protect patients’ access to essential lab tests. |
November 19, 2025 |
ARUP Advocates for the RESULTS Act To Protect Patient Access to Critical Laboratory Testing Services The RESULTS Act offers meaningful reform to a flawed system and will ultimately benefit patients, support innovation, and create stability within the clinical laboratory community. |
Jonathan Genzen, MD, PhD, MBA, ARUP chief medical officer and senior director of governmental affairs, is the new host of LabMind, but he’s no stranger to the mic or the lab. |
November 18, 2025 | Jonathan Genzen, MD, PhD, MBA, ARUP chief medical officer and senior director of governmental affairs, is taking the mic of the LabMind podcast and continuing its legacy of insightful conversations. |
Photo credit: Anne Taylor Cal Taylor sits for a portrait. Cal’s very rare muscle disease was diagnosed by the NeoSeq team within weeks of his birth. |
November 17, 2025 | The Utah NeoSeq Project, a collaboration between ARUP Laboratories and University of Utah Health, is transforming neonatal care using rapid whole genome sequencing (rWGS). |
Kelly Doyle, PhD, DABCC, FADLM, and fellow colleagues have validated age-specific reference intervals to better identify pediatric patients who have glucose-6-phosphate dehydrogenase (G6PD) deficiency. Join Doyle for a webinar, “Development of Pediatric G6PD Reference Intervals Through Integration of Indirect Methods and Molecular Data,” on December 17, 2025, at 11 a.m. |
November 12, 2025 |
ARUP Uses Statistical Modeling To Establish Reference Intervals for Pediatric Patients ARUP has used novel statistical modeling approaches to establish age-specific reference ranges for pediatric patients, facilitating more accurate diagnoses of G6PD deficiency. |
|
November 7, 2025 |
New Resource Discusses DPYD Genotyping Test Selection, Interpretation The FDA and the National Comprehensive Cancer Network (NCCN) urge DPYD testing before chemotherapy. ARUP offers guidance and resources to help clinicians choose and interpret genotyping tests. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat